IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza and Biotech Firm Settle Legal Dispute

11:43 AM MDT | May 6, 2008 | DR

Lonza (Basel, Switzerland) says it has settled a legal dispute with biotechnology company Northwest Biotherapeutics (Bethesda, MD) involving Lonza’s GS Gene Expression System. All claims and counterclaims between the companies are to be dismissed, based on an agreement that Northwest Biotherapeutics will destroy the GS Gene Expression System materials in its possession, Lonza says. The GS Gene Expression System, which is owned and licensed by Lonza, is used to produce therapeutic recombinant proteins and monoclonal antibodies. This system is characterized...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa